🇯🇵·14h agoIndustry
China’s National Medical Products Administration Accepts New Drug Application for IZERVAY™ (avacincaptad pegol) for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Publisher
A
Astellas Pharma
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on newsroom.astellas.com
Leave the platform to read the original full article on the publisher site.
Source: Astellas Pharma
Scope: Industry